Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma

被引：2
作者：
Rutherford, Sarah C. [1 ,2 ,9 ]
Yin, Jun [3 ]
Pederson, Levi D. [3 ]
Blum, Kristie A. [4 ]
Martin, Peter [1 ,2 ]
Jung, Sin -Ho [5 ]
Grant, Barbara [6 ]
Rosenbaum, Cara [1 ,2 ]
Cheson, Bruce D. [7 ]
Bartlett, Nancy L. [8 ]
Mandrekar, Sumithra J. [3 ]
Leonard, John P. [1 ,2 ]
机构：
[1] Weill Cornell Med, Meyer Canc Ctr, Weill Dept Med, Div Hematol & Med Oncol, New York, NY USA
[2] New York Presbyterian Hosp, New York, NY 10033 USA
[3] Mayo Clin, Alliance Stat & Data Management Ctr, Rochester, MN USA
[4] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA
[5] Duke Univ, Duke Canc Inst, Alliance Stat & Data Management Ctr, Biostat & Bioinformat, Durham, NC USA
[6] Univ Vermont, Div Hematol & Oncol, Burlington, VT USA
[7] Lymphoma Res Fdn, Bethesda, MD USA
[8] Washington Univ, Sch Med, Siteman Canc Ctr, Div Oncol, St Louis, MO USA
[9] Weill Cornell Med, 1305 York Ave,7th Floor,Y-764, Y, NY 10021 USA
来源：
BLOOD ADVANCES | 2024年 / 8卷 / 06期
基金：
美国国家卫生研究院;
关键词：
B-CELL LYMPHOMA; COMPUTED-TOMOGRAPHY; RESPONSE ASSESSMENT; SURVEILLANCE; RITUXIMAB; LENALIDOMIDE; THERAPY; RISK;
D O I：
10.1182/bloodadvances.2023012090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1464 / 1468
页数：5
相关论文
共 18 条
  • [1] Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance)
    Blum, Kristie A.
    Polley, Mei-Yin
    Jung, Sin-Ho
    Dockter, Travis J.
    Anderson, Sarah
    Hsi, Eric D.
    Wagner-Johnston, Nina
    Christian, Beth
    Atkins, Jim
    Cheson, Bruce D.
    Leonard, John P.
    Bartlett, Nancy L.
    [J]. CANCER, 2019, 125 (19) : 3378 - 3389
  • [2] Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: A nationwide population-based study
    Chien, Sheng-Hsuan
    Liu, Chia-Jen
    Hu, Yu-Wen
    Hong, Ying-Chung
    Teng, Chung-Jen
    Yeh, Chiu-Mei
    Chiou, Tzeon-Jye
    Gau, Jyh-Pyng
    Tzeng, Cheng-Hwai
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (03) : 658 - 665
  • [3] Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma
    Cohen, Jonathon B.
    Behera, Madhusmita
    Thompson, Carrie A.
    Flowers, Christopher R.
    [J]. BLOOD, 2017, 129 (05) : 561 - 564
  • [4] Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions
    Derry-Vick, Heather M.
    Heathcote, Lauren C.
    Glesby, Nina
    Stribling, Judy
    Luebke, Matthew
    Epstein, Andrew S.
    Prigerson, Holly G.
    [J]. CANCERS, 2023, 15 (05)
  • [5] Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management
    Gerlinger, Marco
    Rohatiner, Ama Z. S.
    Matthews, Janet
    Davies, Andrew
    Lister, T. Andrew
    Montoto, Silvia
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1130 - 1135
  • [6] A Phase 2 Trial of Extended Induction Epratuzumab and Rituximab for Previously Untreated Follicular Lymphoma: CALGB 50701
    Grant, Barbara W.
    Jung, Sin-Ho
    Johnson, Jeffrey L.
    Kostakoglu, Lale
    Hsi, Eric
    Byrd, John C.
    Jones, Jeffrey
    Leonard, John P.
    Martin, S. Eric
    Cheson, Bruce D.
    [J]. CANCER, 2013, 119 (21) : 3797 - 3804
  • [7] The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question
    Hicks, Lisa K.
    Bering, Harriet
    Carson, Kenneth R.
    Kleinerman, Judith
    Kukreti, Vishal
    Ma, Alice
    Mueller, Brigitta U.
    O'Brien, Sarah H.
    Pasquini, Marcelo
    Sarode, Ravindra
    Solberg, Lawrence, Jr.
    Haynes, Adam E.
    Crowther, Mark A.
    [J]. BLOOD, 2013, 122 (24) : 3879 - 3883
  • [8] Whole-Body PET/CT Scanning: Estimation of Radiation Dose and Cancer Risk
    Huang, Bingsheng
    Law, Martin Wai-Ming
    Khong, Pek-Lan
    [J]. RADIOLOGY, 2009, 251 (01) : 166 - 174
  • [9] Cost-Effectiveness Analysis of Routine Surveillance Imaging of Patients With Diffuse Large B-Cell Lymphoma in First Remission
    Huntington, Scott F.
    Svoboda, Jakub
    Doshi, Jalpa A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) : 1467 - 1474
  • [10] A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance)
    Martin, P.
    Jung, S-H
    Pitcher, B.
    Bartlett, N. L.
    Blum, K. A.
    Shea, T.
    Hsi, E. D.
    Ruan, J.
    Smith, S. E.
    Leonard, J. P.
    Cheson, B. D.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (11) : 2806 - 2812
12